Abstract
To assess potential changes in the pathogens attributed to central-line-associated bloodstream infections between 2019 and 2020, hospital data from the National Healthcare Safety Network were analyzed. Compared to 2019, increases in the proportions of pathogens identified as Enterococcus faecalis and coagulase-negative staphylococci were observed during 2020.
Highlights
During 2020, hospitals saw unprecedented increases in critically ill patients as coronavirus disease 2019 (COVID-19) spread across the United States
To assess changes in the common pathogens reported from central line-associated bloodstream infections (CLABSIs) at the national-level between 2019 and 2020, we examined data reported to the National Healthcare Safety Network (NHSN) by acute care hospitals
A large increase in the proportion of intensive care units (ICUs) CLABSI pathogens identified as coagulase-negative staphylococci (CNS) and E. faecalis were noted in 2020 compared to 2019
Summary
During 2020, hospitals saw unprecedented increases in critically ill patients as coronavirus disease 2019 (COVID-19) spread across the United States. Hospitals were often required to modify their operations, services provided, and patient care practices.[1] Several studies have documented an alarming increase in device utilization and healthcare-associated infections (HAIs) in the United States during 2020, in intensive care units (ICUs)[2,3,4]; studies evaluating changes in HAI pathogens during the pandemic have been limited to a small number of facilities. To assess changes in the common pathogens reported from central line-associated bloodstream infections (CLABSIs) at the national-level between 2019 and 2020, we examined data reported to the National Healthcare Safety Network (NHSN) by acute care hospitals
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
